• OPEN AN ACCOUNT
Indian Indices
Sensex
84,559.65 -120.21
( -0.14%)
Global Indices
Nasdaq
48,129.39 -308.18
(-0.64%)
Dow Jones
6,819.35 -18.16
(-0.27%)
Hang Seng
49,518.65 135.36
(0.27%)
Nikkei 225
9,668.67 -82.64
(-0.85%)
Forex
USD-INR
90.68 0.14
(0.16%)
EUR-INR
106.49 0.21
(0.20%)
GBP-INR
121.26 0.23
(0.19%)
JPY-INR
0.58 0.00
(0.55%)

EQUITY - MARKET SCREENER

Hindustan Construction Company Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
500185
INE549A01026
11.4226149
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HCC
53.94
4662.65
EPS(TTM)
Face Value()
Div & Yield %
0.33
1
0
 

Pfizer jumps after robust Q1 earnings
Aug 14,2025
On a standalone basis, net profit rose 27.23% year-on-year to Rs 191.75 crore in Q1 FY26 from Rs 150.71 crore in Q1 FY25, but fell 3.3% sequentially from adjusted net profit of Rs 198.33 crore in Q4 FY25.

Revenue from operations stood at Rs 603.05 crore, up 7.14% YoY from Rs 562.86 crore and 1.88% higher than Rs 591.91 crore in the March quarter.

Profit before tax and exceptional items stood at Rs 259.53 crore in Q1 FY26, up 28.09% YoY and up 2.59% from Rs 252.99 crore in Q4 FY25.

Total expenditure rose 1.99% YoY to Rs 393.03 crore from Rs 385.37 crore and was up 7.86% sequentially from Rs 364.41 crore. Cost of material consumed jumped 53.60% YoY to Rs 88.69 crore in Q1 FY26.

Pfizer is one of the world’s leading pharmaceutical companies, specialising in four key business categories — vaccines, hospitals, internal medicine, and inflammation & immunology.